fat Search Results


92
TaKaRa human t cell cdna library
Comparison of relative lengths of envelope glycoprotein cytoplasmic domain sequences from 10 different retroviruses. Scale is in numbers of amino acids. HTLV-1, human T-cell lymphotropic virus type 1; MPMV, Mason-Pfizer monkey virus; MoMLV, Moloney murine leukemia virus.
Human T Cell Cdna Library, supplied by TaKaRa, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fat/Human+Fat+Cell+QUICK-Clone+cDNA/pmc00135700-62-25-29
Average 92 stars, based on 1 article reviews
human t cell cdna library - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

95
Labconco petroleum ether
Comparison of relative lengths of envelope glycoprotein cytoplasmic domain sequences from 10 different retroviruses. Scale is in numbers of amino acids. HTLV-1, human T-cell lymphotropic virus type 1; MPMV, Mason-Pfizer monkey virus; MoMLV, Moloney murine leukemia virus.
Petroleum Ether, supplied by Labconco, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fat/Goldfisch+Fat+Extractor/pm08786257-74-7-25
Average 95 stars, based on 1 article reviews
petroleum ether - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
Miltenyi Biotec cd36 pevio770
Flow cytometry antibodies used.
Cd36 Pevio770, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fat/CD36+Antibody%2C+anti-human%2C+REAfinity/pmc08070390-28-0-2
Average 94 stars, based on 1 article reviews
cd36 pevio770 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc fat1 antibody
A : Scatter plot representing normalized mRNA expression of STAT1 and <t>FAT1</t> in TCGA glioblastoma patient (cell 2013) available at GDC TCGA. STAT1 showed a positive Spearman correlation with FAT1 (correlation coefficient r = 0.18) in 141 patients. B: Scatter plot representing normalized mRNA expression of STAT4 and FAT1 in TCGA glioblastoma patient (cell 2013) available at GDC TCGA. STAT4 showed no significant Spearman correlation with FAT1. C, D: Dot plots representing normalized mRNA expression of FAT1 -STAT1 and FAT1-STAT4 respectively in microarray Loeffler Data available at R2 genomics and analysis platform of 70 patients. STAT1 showed a positive Spearman correlation with r = 0.24 and p value 0.04 while FAT1 and STAT4 have no significant correlation. E, F: Scatter plot representing the normalized mRNA expression accessed by Real-Time PCR of FAT1-STAT1 and FAT1-STAT4 respectively in 33 Glioblastoma resected samples. STAT1 showed a significant positive Spearman correlation of 0.53 with p value 0.0015 while STAT4 showed no positive correlation with FAT1.
Fat1 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fat/FAT1+Antibody/bio_rxiv__2023__09__22__558772-54-6-17
Average 94 stars, based on 1 article reviews
fat1 antibody - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

91
Biorbyt non fat milk
A : Scatter plot representing normalized mRNA expression of STAT1 and <t>FAT1</t> in TCGA glioblastoma patient (cell 2013) available at GDC TCGA. STAT1 showed a positive Spearman correlation with FAT1 (correlation coefficient r = 0.18) in 141 patients. B: Scatter plot representing normalized mRNA expression of STAT4 and FAT1 in TCGA glioblastoma patient (cell 2013) available at GDC TCGA. STAT4 showed no significant Spearman correlation with FAT1. C, D: Dot plots representing normalized mRNA expression of FAT1 -STAT1 and FAT1-STAT4 respectively in microarray Loeffler Data available at R2 genomics and analysis platform of 70 patients. STAT1 showed a positive Spearman correlation with r = 0.24 and p value 0.04 while FAT1 and STAT4 have no significant correlation. E, F: Scatter plot representing the normalized mRNA expression accessed by Real-Time PCR of FAT1-STAT1 and FAT1-STAT4 respectively in 33 Glioblastoma resected samples. STAT1 showed a significant positive Spearman correlation of 0.53 with p value 0.0015 while STAT4 showed no positive correlation with FAT1.
Non Fat Milk, supplied by Biorbyt, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fat/FAT+antibody/pm36638871-153-5-21
Average 91 stars, based on 1 article reviews
non fat milk - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

96
Bio-Rad blotting grade blocker non fat dry milk
A : Scatter plot representing normalized mRNA expression of STAT1 and <t>FAT1</t> in TCGA glioblastoma patient (cell 2013) available at GDC TCGA. STAT1 showed a positive Spearman correlation with FAT1 (correlation coefficient r = 0.18) in 141 patients. B: Scatter plot representing normalized mRNA expression of STAT4 and FAT1 in TCGA glioblastoma patient (cell 2013) available at GDC TCGA. STAT4 showed no significant Spearman correlation with FAT1. C, D: Dot plots representing normalized mRNA expression of FAT1 -STAT1 and FAT1-STAT4 respectively in microarray Loeffler Data available at R2 genomics and analysis platform of 70 patients. STAT1 showed a positive Spearman correlation with r = 0.24 and p value 0.04 while FAT1 and STAT4 have no significant correlation. E, F: Scatter plot representing the normalized mRNA expression accessed by Real-Time PCR of FAT1-STAT1 and FAT1-STAT4 respectively in 33 Glioblastoma resected samples. STAT1 showed a significant positive Spearman correlation of 0.53 with p value 0.0015 while STAT4 showed no positive correlation with FAT1.
Blotting Grade Blocker Non Fat Dry Milk, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fat/Blotting+Grade+Blocker+Non+Fat+Dry+Milk/pm20610160-139-8-14
Average 96 stars, based on 1 article reviews
blotting grade blocker non fat dry milk - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Proteintech cd36
A : Scatter plot representing normalized mRNA expression of STAT1 and <t>FAT1</t> in TCGA glioblastoma patient (cell 2013) available at GDC TCGA. STAT1 showed a positive Spearman correlation with FAT1 (correlation coefficient r = 0.18) in 141 patients. B: Scatter plot representing normalized mRNA expression of STAT4 and FAT1 in TCGA glioblastoma patient (cell 2013) available at GDC TCGA. STAT4 showed no significant Spearman correlation with FAT1. C, D: Dot plots representing normalized mRNA expression of FAT1 -STAT1 and FAT1-STAT4 respectively in microarray Loeffler Data available at R2 genomics and analysis platform of 70 patients. STAT1 showed a positive Spearman correlation with r = 0.24 and p value 0.04 while FAT1 and STAT4 have no significant correlation. E, F: Scatter plot representing the normalized mRNA expression accessed by Real-Time PCR of FAT1-STAT1 and FAT1-STAT4 respectively in 33 Glioblastoma resected samples. STAT1 showed a significant positive Spearman correlation of 0.53 with p value 0.0015 while STAT4 showed no positive correlation with FAT1.
Cd36, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fat/CD36+Antibody/pmc13015209-54-26-60
Average 96 stars, based on 1 article reviews
cd36 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology blotto
A : Scatter plot representing normalized mRNA expression of STAT1 and <t>FAT1</t> in TCGA glioblastoma patient (cell 2013) available at GDC TCGA. STAT1 showed a positive Spearman correlation with FAT1 (correlation coefficient r = 0.18) in 141 patients. B: Scatter plot representing normalized mRNA expression of STAT4 and FAT1 in TCGA glioblastoma patient (cell 2013) available at GDC TCGA. STAT4 showed no significant Spearman correlation with FAT1. C, D: Dot plots representing normalized mRNA expression of FAT1 -STAT1 and FAT1-STAT4 respectively in microarray Loeffler Data available at R2 genomics and analysis platform of 70 patients. STAT1 showed a positive Spearman correlation with r = 0.24 and p value 0.04 while FAT1 and STAT4 have no significant correlation. E, F: Scatter plot representing the normalized mRNA expression accessed by Real-Time PCR of FAT1-STAT1 and FAT1-STAT4 respectively in 33 Glioblastoma resected samples. STAT1 showed a significant positive Spearman correlation of 0.53 with p value 0.0015 while STAT4 showed no positive correlation with FAT1.
Blotto, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fat/Blotto%2C+non-fat+dry+milk/pm41413387-469-5-6
Average 94 stars, based on 1 article reviews
blotto - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Rockland Immunochemicals paraformaldehyde
A : Scatter plot representing normalized mRNA expression of STAT1 and <t>FAT1</t> in TCGA glioblastoma patient (cell 2013) available at GDC TCGA. STAT1 showed a positive Spearman correlation with FAT1 (correlation coefficient r = 0.18) in 141 patients. B: Scatter plot representing normalized mRNA expression of STAT4 and FAT1 in TCGA glioblastoma patient (cell 2013) available at GDC TCGA. STAT4 showed no significant Spearman correlation with FAT1. C, D: Dot plots representing normalized mRNA expression of FAT1 -STAT1 and FAT1-STAT4 respectively in microarray Loeffler Data available at R2 genomics and analysis platform of 70 patients. STAT1 showed a positive Spearman correlation with r = 0.24 and p value 0.04 while FAT1 and STAT4 have no significant correlation. E, F: Scatter plot representing the normalized mRNA expression accessed by Real-Time PCR of FAT1-STAT1 and FAT1-STAT4 respectively in 33 Glioblastoma resected samples. STAT1 showed a significant positive Spearman correlation of 0.53 with p value 0.0015 while STAT4 showed no positive correlation with FAT1.
Paraformaldehyde, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fat/Blotto+B+Pre-Mixed/bio_rxiv__2025__02__12__637793-326-24-37
Average 93 stars, based on 1 article reviews
paraformaldehyde - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

92
Santa Cruz Biotechnology anti fat1
A : Scatter plot representing normalized mRNA expression of STAT1 and <t>FAT1</t> in TCGA glioblastoma patient (cell 2013) available at GDC TCGA. STAT1 showed a positive Spearman correlation with FAT1 (correlation coefficient r = 0.18) in 141 patients. B: Scatter plot representing normalized mRNA expression of STAT4 and FAT1 in TCGA glioblastoma patient (cell 2013) available at GDC TCGA. STAT4 showed no significant Spearman correlation with FAT1. C, D: Dot plots representing normalized mRNA expression of FAT1 -STAT1 and FAT1-STAT4 respectively in microarray Loeffler Data available at R2 genomics and analysis platform of 70 patients. STAT1 showed a positive Spearman correlation with r = 0.24 and p value 0.04 while FAT1 and STAT4 have no significant correlation. E, F: Scatter plot representing the normalized mRNA expression accessed by Real-Time PCR of FAT1-STAT1 and FAT1-STAT4 respectively in 33 Glioblastoma resected samples. STAT1 showed a significant positive Spearman correlation of 0.53 with p value 0.0015 while STAT4 showed no positive correlation with FAT1.
Anti Fat1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fat/FAT1+Antibody/pmc03943818-86-11-15
Average 92 stars, based on 1 article reviews
anti fat1 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

93
ABclonal Biotechnology fat4
A Mass spectroscopic analysis of Up-regulated and down-regulated protein. B Volcano plot showing differentially expressed proteins ( P < 0.05, FC < 1/1.2 & FC > 1.2). C Heatmap shows a differentially expressed gene. D KEGG enrichment analysis top 20. E KEGG Level 3 shows differential protein distribution. F Western blot detected <t>FAT4</t> protein in MKN45 or AGS cells after transfecting cells with three independent siRNA or UBE4B overexpression plasmid. G Western blot detected P62 and LC3II/I protein in MKN45 or AGS cells after transfecting cells with three independent siRNA or UBE4B overexpression plasmid.
Fat4, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fat/FAT4+Rabbit+pAb/pmc12287395-305-12-14
Average 93 stars, based on 1 article reviews
fat4 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
ABclonal Biotechnology antibodies for cd36
Screening hub genes related to efferocytosis in diabetic kidney macrophages. The GO enrichment analysis of macrophage subpopulations in 3-month-old (A) and 7-month-old mice (B) . (C) The chord diagram about the interaction among renal immune cells. (D) The Venn diagram illustrating the intersection between GSE195799 and the gene list of efferocytosis. (E) The PPI diagram, where the color varies from light to dark, signifies an ascending order of degree. (F–H) Violin diagrams of the distribution of <t>CD36,</t> ITGAM, and CX3CR1 in each cluster. GO, gene ontology; MIF, macrophage migration inhibitory factor; PPI, protein-protein interaction network.
Antibodies For Cd36, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fat/CD36+Rabbit+mAb/pmc11879818-90-11-15
Average 93 stars, based on 1 article reviews
antibodies for cd36 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

Image Search Results


Comparison of relative lengths of envelope glycoprotein cytoplasmic domain sequences from 10 different retroviruses. Scale is in numbers of amino acids. HTLV-1, human T-cell lymphotropic virus type 1; MPMV, Mason-Pfizer monkey virus; MoMLV, Moloney murine leukemia virus.

Journal:

Article Title: Envelope Glycoprotein Cytoplasmic Domains from Diverse Lentiviruses Interact with the Prenylated Rab Acceptor

doi: 10.1128/JVI.76.1.327-337.2002

Figure Lengend Snippet: Comparison of relative lengths of envelope glycoprotein cytoplasmic domain sequences from 10 different retroviruses. Scale is in numbers of amino acids. HTLV-1, human T-cell lymphotropic virus type 1; MPMV, Mason-Pfizer monkey virus; MoMLV, Moloney murine leukemia virus.

Article Snippet: A yeast two-hybrid screen for cellular binding partners to the SIV gp41 CD was performed using the yeast two-hybrid system 3 and a phytohemagglutinin (PHA)-activated human T-cell cDNA library (Clontech, Palo Alto, Calif.) ( 15 ).

Techniques:

Flow cytometry antibodies used.

Journal: Cancers

Article Title: Murlentamab, a Low Fucosylated Anti-Müllerian Hormone Type II Receptor (AMHRII) Antibody, Exhibits Anti-Tumor Activity through Tumor-Associated Macrophage Reprogrammation and T Cell Activation

doi: 10.3390/cancers13081845

Figure Lengend Snippet: Flow cytometry antibodies used.

Article Snippet: CD36-PEVio770 , Miltenyi , 130-110-742 , REA770 , .

Techniques: Flow Cytometry, In Vivo, In Vitro

Murlentamab opsonization of SKOV3-R2 + orients naïve macrophages and reprograms TAMs towards an M1-like profile. SKOV3-R2 + ovarian tumor cells were labeled with different 3C23K antibodies (3C23K-FcKO control, 3C23K-CHO normally fucosylated or murlentamab the low fucosylated form) and cultured in the presence of human monocyte-derived macrophages from healthy donors unstimulated (M0) or stimulated with M-CSF and IL-10 (TAMs). ( A ) The proportion of macrophages expressing M1/M2 membrane markers (CD32, CD64, CD80, TLR2, CD163, CD36 and CD206) was determined by flow cytometry after three days of co-culture with SKOV3-R2 + cells. ( B ) The release of cytokines (IL1β, IL12, TNFα, IL6, IFNγ, IL10) and chemokines (CCL2, CCL4, CCL5, CXCL9 and CXCL10) in the culture medium was determined by AlphaLISA after three days of co-culture with SKOV3-R2 + cells. Data shown (boxplots) are the results from three different experiments (performed with three different healthy donors). * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. p values were determined using one-way ANOVA analysis followed by Tukey’s multiple comparisons test.

Journal: Cancers

Article Title: Murlentamab, a Low Fucosylated Anti-Müllerian Hormone Type II Receptor (AMHRII) Antibody, Exhibits Anti-Tumor Activity through Tumor-Associated Macrophage Reprogrammation and T Cell Activation

doi: 10.3390/cancers13081845

Figure Lengend Snippet: Murlentamab opsonization of SKOV3-R2 + orients naïve macrophages and reprograms TAMs towards an M1-like profile. SKOV3-R2 + ovarian tumor cells were labeled with different 3C23K antibodies (3C23K-FcKO control, 3C23K-CHO normally fucosylated or murlentamab the low fucosylated form) and cultured in the presence of human monocyte-derived macrophages from healthy donors unstimulated (M0) or stimulated with M-CSF and IL-10 (TAMs). ( A ) The proportion of macrophages expressing M1/M2 membrane markers (CD32, CD64, CD80, TLR2, CD163, CD36 and CD206) was determined by flow cytometry after three days of co-culture with SKOV3-R2 + cells. ( B ) The release of cytokines (IL1β, IL12, TNFα, IL6, IFNγ, IL10) and chemokines (CCL2, CCL4, CCL5, CXCL9 and CXCL10) in the culture medium was determined by AlphaLISA after three days of co-culture with SKOV3-R2 + cells. Data shown (boxplots) are the results from three different experiments (performed with three different healthy donors). * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. p values were determined using one-way ANOVA analysis followed by Tukey’s multiple comparisons test.

Article Snippet: CD36-PEVio770 , Miltenyi , 130-110-742 , REA770 , .

Techniques: Labeling, Cell Culture, Derivative Assay, Expressing, Membrane, Flow Cytometry, Co-Culture Assay

A : Scatter plot representing normalized mRNA expression of STAT1 and FAT1 in TCGA glioblastoma patient (cell 2013) available at GDC TCGA. STAT1 showed a positive Spearman correlation with FAT1 (correlation coefficient r = 0.18) in 141 patients. B: Scatter plot representing normalized mRNA expression of STAT4 and FAT1 in TCGA glioblastoma patient (cell 2013) available at GDC TCGA. STAT4 showed no significant Spearman correlation with FAT1. C, D: Dot plots representing normalized mRNA expression of FAT1 -STAT1 and FAT1-STAT4 respectively in microarray Loeffler Data available at R2 genomics and analysis platform of 70 patients. STAT1 showed a positive Spearman correlation with r = 0.24 and p value 0.04 while FAT1 and STAT4 have no significant correlation. E, F: Scatter plot representing the normalized mRNA expression accessed by Real-Time PCR of FAT1-STAT1 and FAT1-STAT4 respectively in 33 Glioblastoma resected samples. STAT1 showed a significant positive Spearman correlation of 0.53 with p value 0.0015 while STAT4 showed no positive correlation with FAT1.

Journal: bioRxiv

Article Title: The atypical cadherin FAT1 is a novel regulator of STAT1, driving its pro-tumorigenic effect via the STAT1/PDCD4 axis in glioblastoma

doi: 10.1101/2023.09.22.558772

Figure Lengend Snippet: A : Scatter plot representing normalized mRNA expression of STAT1 and FAT1 in TCGA glioblastoma patient (cell 2013) available at GDC TCGA. STAT1 showed a positive Spearman correlation with FAT1 (correlation coefficient r = 0.18) in 141 patients. B: Scatter plot representing normalized mRNA expression of STAT4 and FAT1 in TCGA glioblastoma patient (cell 2013) available at GDC TCGA. STAT4 showed no significant Spearman correlation with FAT1. C, D: Dot plots representing normalized mRNA expression of FAT1 -STAT1 and FAT1-STAT4 respectively in microarray Loeffler Data available at R2 genomics and analysis platform of 70 patients. STAT1 showed a positive Spearman correlation with r = 0.24 and p value 0.04 while FAT1 and STAT4 have no significant correlation. E, F: Scatter plot representing the normalized mRNA expression accessed by Real-Time PCR of FAT1-STAT1 and FAT1-STAT4 respectively in 33 Glioblastoma resected samples. STAT1 showed a significant positive Spearman correlation of 0.53 with p value 0.0015 while STAT4 showed no positive correlation with FAT1.

Article Snippet: Antibodies used for Western blot were FAT1 antibody (NB100-2693; 1:500; 508 kDa), STAT1 antibody (9172S,1:1000), PDCD4 (D29C6,1:1000) (Cell Signaling technologies), β-Actin (AB8227; 1:5000; 42kDa).

Techniques: Expressing, Microarray, Real-time Polymerase Chain Reaction

A, B. Graphs representing fold mRNA expression in U87MG and LN229 cells treated with SiControl and siFAT1. Knockdown of FAT1 in U87MG cells and LN229 led to increased mRNA expression of PDCD4 (> 2 folds), STAT1 mRNA expression decreased (= 1.5 folds) assessed by qPCR experiment. C.D. Western Blot showing the effect of FAT1 knockdown on STAT1. E.F. Decrease in STAT1 Blot intensity (≥ 2folds) in U87MG and LN229 cells respectively, analyzed by Image Software. G. ICC Image of anti-STAT1 antibody showing STAT1 expression. H. Graph representing the mean fluorescence intensity of STAT1 antibody in control cells and FAT1 knockdown cells. Data presented as mean ±SD *p<0.05, **p<0.005 and ***p<0.0005.

Journal: bioRxiv

Article Title: The atypical cadherin FAT1 is a novel regulator of STAT1, driving its pro-tumorigenic effect via the STAT1/PDCD4 axis in glioblastoma

doi: 10.1101/2023.09.22.558772

Figure Lengend Snippet: A, B. Graphs representing fold mRNA expression in U87MG and LN229 cells treated with SiControl and siFAT1. Knockdown of FAT1 in U87MG cells and LN229 led to increased mRNA expression of PDCD4 (> 2 folds), STAT1 mRNA expression decreased (= 1.5 folds) assessed by qPCR experiment. C.D. Western Blot showing the effect of FAT1 knockdown on STAT1. E.F. Decrease in STAT1 Blot intensity (≥ 2folds) in U87MG and LN229 cells respectively, analyzed by Image Software. G. ICC Image of anti-STAT1 antibody showing STAT1 expression. H. Graph representing the mean fluorescence intensity of STAT1 antibody in control cells and FAT1 knockdown cells. Data presented as mean ±SD *p<0.05, **p<0.005 and ***p<0.0005.

Article Snippet: Antibodies used for Western blot were FAT1 antibody (NB100-2693; 1:500; 508 kDa), STAT1 antibody (9172S,1:1000), PDCD4 (D29C6,1:1000) (Cell Signaling technologies), β-Actin (AB8227; 1:5000; 42kDa).

Techniques: Expressing, Knockdown, Western Blot, Software, Fluorescence, Control

A, B. Increase in PDCD4 luciferase activity on FAT1 knockdown in LN229 cells (≥ 2 folds p≤ 0.005) and on STAT1 knockdown in LN229 cells (≥ 1.4 folds, p ≤ 0.05) C. Diagrammatic representation of the deleted nucleotides by SDM to disrupt STAT1 binding sites on PDCD4 promoter site 1 D. PDCD4 promoter luciferase activity increases by 2.8 folds (p-value: < 0.005) on Site-Directed deletion of four nucleotides of STAT1 binding sites.

Journal: bioRxiv

Article Title: The atypical cadherin FAT1 is a novel regulator of STAT1, driving its pro-tumorigenic effect via the STAT1/PDCD4 axis in glioblastoma

doi: 10.1101/2023.09.22.558772

Figure Lengend Snippet: A, B. Increase in PDCD4 luciferase activity on FAT1 knockdown in LN229 cells (≥ 2 folds p≤ 0.005) and on STAT1 knockdown in LN229 cells (≥ 1.4 folds, p ≤ 0.05) C. Diagrammatic representation of the deleted nucleotides by SDM to disrupt STAT1 binding sites on PDCD4 promoter site 1 D. PDCD4 promoter luciferase activity increases by 2.8 folds (p-value: < 0.005) on Site-Directed deletion of four nucleotides of STAT1 binding sites.

Article Snippet: Antibodies used for Western blot were FAT1 antibody (NB100-2693; 1:500; 508 kDa), STAT1 antibody (9172S,1:1000), PDCD4 (D29C6,1:1000) (Cell Signaling technologies), β-Actin (AB8227; 1:5000; 42kDa).

Techniques: Luciferase, Activity Assay, Knockdown, Binding Assay

A proposed model showing a novel oncogenic signalling axis between FAT1-STAT1 in downregulating PDCD4, increasing expression of pro-tumorigenic inflammatory cytokines COX-2, IL6 and IL1B and increasing EMT, Invasion and migration.

Journal: bioRxiv

Article Title: The atypical cadherin FAT1 is a novel regulator of STAT1, driving its pro-tumorigenic effect via the STAT1/PDCD4 axis in glioblastoma

doi: 10.1101/2023.09.22.558772

Figure Lengend Snippet: A proposed model showing a novel oncogenic signalling axis between FAT1-STAT1 in downregulating PDCD4, increasing expression of pro-tumorigenic inflammatory cytokines COX-2, IL6 and IL1B and increasing EMT, Invasion and migration.

Article Snippet: Antibodies used for Western blot were FAT1 antibody (NB100-2693; 1:500; 508 kDa), STAT1 antibody (9172S,1:1000), PDCD4 (D29C6,1:1000) (Cell Signaling technologies), β-Actin (AB8227; 1:5000; 42kDa).

Techniques: Expressing, Migration

A Mass spectroscopic analysis of Up-regulated and down-regulated protein. B Volcano plot showing differentially expressed proteins ( P < 0.05, FC < 1/1.2 & FC > 1.2). C Heatmap shows a differentially expressed gene. D KEGG enrichment analysis top 20. E KEGG Level 3 shows differential protein distribution. F Western blot detected FAT4 protein in MKN45 or AGS cells after transfecting cells with three independent siRNA or UBE4B overexpression plasmid. G Western blot detected P62 and LC3II/I protein in MKN45 or AGS cells after transfecting cells with three independent siRNA or UBE4B overexpression plasmid.

Journal: Cell Death & Disease

Article Title: UBE4B promotes gastric cancer proliferation and metastasis by mediating FAT4 ubiquitination and degradation

doi: 10.1038/s41419-025-07794-8

Figure Lengend Snippet: A Mass spectroscopic analysis of Up-regulated and down-regulated protein. B Volcano plot showing differentially expressed proteins ( P < 0.05, FC < 1/1.2 & FC > 1.2). C Heatmap shows a differentially expressed gene. D KEGG enrichment analysis top 20. E KEGG Level 3 shows differential protein distribution. F Western blot detected FAT4 protein in MKN45 or AGS cells after transfecting cells with three independent siRNA or UBE4B overexpression plasmid. G Western blot detected P62 and LC3II/I protein in MKN45 or AGS cells after transfecting cells with three independent siRNA or UBE4B overexpression plasmid.

Article Snippet: The antibodies used in this study were as follows: UBE4B (18148-1-AP, Proteintech), FAT4 (A17212, ABclonal), FAT4 (NBP1-78381, Novus), P62 (#7695, Cell Signaling), LC3 (#12741, Cell Signaling), ubiquitin (10201-1-AP, Proteintech), Ki67 (#9449, Cell Signaling), HA (20543-1-AP, Proteintech), MYC (390003, Zenbio), and GAPDH (HC301-01, TransGen Biotech).

Techniques: Western Blot, Over Expression, Plasmid Preparation

A Transmission electron microscopy observation of autophagosomes in UBE4B-knockdown MKN45 cells. B, C MKN45 cells transfected with two independent siUBE4B were treated with 20 μM cycloheximide (CHX) for 0, 2, 4, 6, 8, and 12 h, and the UBE4B and FAT4 protein levels were detected by Western blot. D Western blotting was conducted to measure FAT4 protein level after treatment with 20 μM MG132 in knockdown UBE4B and control GC cells. E, F Western blotting was conducted to measure the level of ubiquitin when knockdown or overexpression UBE4B.

Journal: Cell Death & Disease

Article Title: UBE4B promotes gastric cancer proliferation and metastasis by mediating FAT4 ubiquitination and degradation

doi: 10.1038/s41419-025-07794-8

Figure Lengend Snippet: A Transmission electron microscopy observation of autophagosomes in UBE4B-knockdown MKN45 cells. B, C MKN45 cells transfected with two independent siUBE4B were treated with 20 μM cycloheximide (CHX) for 0, 2, 4, 6, 8, and 12 h, and the UBE4B and FAT4 protein levels were detected by Western blot. D Western blotting was conducted to measure FAT4 protein level after treatment with 20 μM MG132 in knockdown UBE4B and control GC cells. E, F Western blotting was conducted to measure the level of ubiquitin when knockdown or overexpression UBE4B.

Article Snippet: The antibodies used in this study were as follows: UBE4B (18148-1-AP, Proteintech), FAT4 (A17212, ABclonal), FAT4 (NBP1-78381, Novus), P62 (#7695, Cell Signaling), LC3 (#12741, Cell Signaling), ubiquitin (10201-1-AP, Proteintech), Ki67 (#9449, Cell Signaling), HA (20543-1-AP, Proteintech), MYC (390003, Zenbio), and GAPDH (HC301-01, TransGen Biotech).

Techniques: Transmission Assay, Electron Microscopy, Knockdown, Transfection, Western Blot, Control, Ubiquitin Proteomics, Over Expression

A Schematic representation of the docking structure of protein molecules. Blue color indicates UBE4B protein and yellow color indicates FAT4 protein. The key interacting residues are highlighted in red font. B Segment plasmid of UBE4B. C , D Endogenous UBE4B proteins were immunoprecipitated with an anti-UBE4B antibody and then analyzed by immunoblotting. Endogenous FAT4 proteins were immunoprecipitated with anti-FAT4 antibodies and then analyzed by immunoblotting. The IgG antibody was used as the control. E HEK-293T cells infected endogenous overexpression of FAT4 lentivirus and HA-UBE4B plasmid were subject to immunoprecipitation with anti-UBE4B and anti-FAT4 antibodies. F HEK-293T cells infected endogenous overexpression of FAT4 lentivirus were transfected with HA-UBE4B or several UBE4B mutants. A coimmunoprecipitation assay was performed to detect the interaction between UBE4B and FAT4 protein. G HEK-293T cells infected with endogenous overexpression of FAT4 lentivirus were transfected with HA-UBE4B or wild-type Ub, Ub-K6R, K11R, K27R, K29R, K33R, K48R, and K63R plasmid. Cell lysates were assayed for ubiquitination, and the ubiquitination level of FAT4 was detected. H HEK-293T cells infected with endogenous overexpression of FAT4 lentivirus were transfected with HA-UBE4B or wild-type Ub, Ub-K6R, K33R and K6R/K33R plasmid. Cell lysates were assayed for ubiquitination, and the ubiquitination level of FAT4 was detected.

Journal: Cell Death & Disease

Article Title: UBE4B promotes gastric cancer proliferation and metastasis by mediating FAT4 ubiquitination and degradation

doi: 10.1038/s41419-025-07794-8

Figure Lengend Snippet: A Schematic representation of the docking structure of protein molecules. Blue color indicates UBE4B protein and yellow color indicates FAT4 protein. The key interacting residues are highlighted in red font. B Segment plasmid of UBE4B. C , D Endogenous UBE4B proteins were immunoprecipitated with an anti-UBE4B antibody and then analyzed by immunoblotting. Endogenous FAT4 proteins were immunoprecipitated with anti-FAT4 antibodies and then analyzed by immunoblotting. The IgG antibody was used as the control. E HEK-293T cells infected endogenous overexpression of FAT4 lentivirus and HA-UBE4B plasmid were subject to immunoprecipitation with anti-UBE4B and anti-FAT4 antibodies. F HEK-293T cells infected endogenous overexpression of FAT4 lentivirus were transfected with HA-UBE4B or several UBE4B mutants. A coimmunoprecipitation assay was performed to detect the interaction between UBE4B and FAT4 protein. G HEK-293T cells infected with endogenous overexpression of FAT4 lentivirus were transfected with HA-UBE4B or wild-type Ub, Ub-K6R, K11R, K27R, K29R, K33R, K48R, and K63R plasmid. Cell lysates were assayed for ubiquitination, and the ubiquitination level of FAT4 was detected. H HEK-293T cells infected with endogenous overexpression of FAT4 lentivirus were transfected with HA-UBE4B or wild-type Ub, Ub-K6R, K33R and K6R/K33R plasmid. Cell lysates were assayed for ubiquitination, and the ubiquitination level of FAT4 was detected.

Article Snippet: The antibodies used in this study were as follows: UBE4B (18148-1-AP, Proteintech), FAT4 (A17212, ABclonal), FAT4 (NBP1-78381, Novus), P62 (#7695, Cell Signaling), LC3 (#12741, Cell Signaling), ubiquitin (10201-1-AP, Proteintech), Ki67 (#9449, Cell Signaling), HA (20543-1-AP, Proteintech), MYC (390003, Zenbio), and GAPDH (HC301-01, TransGen Biotech).

Techniques: Plasmid Preparation, Immunoprecipitation, Western Blot, Control, Infection, Over Expression, Transfection, Co-Immunoprecipitation Assay, Ubiquitin Proteomics

A MKN45 cells with/without shUBE4B were injected in nude mice. Representative images of xenograft tumors from mice bearing MKN45-shNC and MKN45-shUBE4B cells. B Tumor weights were calculated for each mouse in both groups ( n = 6, Student’s t test). C Tumor volume was measured every 5 days ( n = 6, Student’s t test). D IHC scores were analyzed for the expression levels of UBE4B, FAT4, and Ki67 in both groups (NC vs UBE4B-OE, n = 15, Student’s t test). E , F UBE4B, FAT4, and Ki67 expression in the tumor of nude mice were detected by IHC. Bar length: 50 μm. G MKN45 cells with/without shUBE4B or with/without FAT4 were injected in nude mice. Representative images of xenograft tumors from mice bearing MKN45-shNC+shNC, MKN45-shUBE4B+shNC, and MKN45-shUBE4B+shFAT4 cells. H Tumor weights were calculated for each mouse in the three groups ( n = 10, One-way ANOVA). I Tumor volume was measured every 3 days ( n = 10, One-way ANOVA). J IHC scores were analyzed for the expression levels of UBE4B, FAT4, and Ki67 in the three groups (NC + NC vs KD-UBE4B + NC vs KD-UBE4B + KD-FAT4, n = 15, One-way ANOVA).

Journal: Cell Death & Disease

Article Title: UBE4B promotes gastric cancer proliferation and metastasis by mediating FAT4 ubiquitination and degradation

doi: 10.1038/s41419-025-07794-8

Figure Lengend Snippet: A MKN45 cells with/without shUBE4B were injected in nude mice. Representative images of xenograft tumors from mice bearing MKN45-shNC and MKN45-shUBE4B cells. B Tumor weights were calculated for each mouse in both groups ( n = 6, Student’s t test). C Tumor volume was measured every 5 days ( n = 6, Student’s t test). D IHC scores were analyzed for the expression levels of UBE4B, FAT4, and Ki67 in both groups (NC vs UBE4B-OE, n = 15, Student’s t test). E , F UBE4B, FAT4, and Ki67 expression in the tumor of nude mice were detected by IHC. Bar length: 50 μm. G MKN45 cells with/without shUBE4B or with/without FAT4 were injected in nude mice. Representative images of xenograft tumors from mice bearing MKN45-shNC+shNC, MKN45-shUBE4B+shNC, and MKN45-shUBE4B+shFAT4 cells. H Tumor weights were calculated for each mouse in the three groups ( n = 10, One-way ANOVA). I Tumor volume was measured every 3 days ( n = 10, One-way ANOVA). J IHC scores were analyzed for the expression levels of UBE4B, FAT4, and Ki67 in the three groups (NC + NC vs KD-UBE4B + NC vs KD-UBE4B + KD-FAT4, n = 15, One-way ANOVA).

Article Snippet: The antibodies used in this study were as follows: UBE4B (18148-1-AP, Proteintech), FAT4 (A17212, ABclonal), FAT4 (NBP1-78381, Novus), P62 (#7695, Cell Signaling), LC3 (#12741, Cell Signaling), ubiquitin (10201-1-AP, Proteintech), Ki67 (#9449, Cell Signaling), HA (20543-1-AP, Proteintech), MYC (390003, Zenbio), and GAPDH (HC301-01, TransGen Biotech).

Techniques: Injection, Expressing

A Representative image of IHC staining of tumor microarrays from GC patients. Bar length: 50 μm. B IHC scores of UBE4B level between GC tissue and adjacent normal tissue. C IHC scores of FAT4 level between GC tissue and adjacent normal tissue. D The Kaplan-Meier plot of overall survival by the expression of UBE4B in tumor microarrays related information ( n = 66 (high-expression) vs 28 (low-expression)). E The Kaplan-Meier plot of overall survival by the expression of FAT4 in tumor microarrays related information ( n = 46 (high-expression) vs 48 (low-expression)).

Journal: Cell Death & Disease

Article Title: UBE4B promotes gastric cancer proliferation and metastasis by mediating FAT4 ubiquitination and degradation

doi: 10.1038/s41419-025-07794-8

Figure Lengend Snippet: A Representative image of IHC staining of tumor microarrays from GC patients. Bar length: 50 μm. B IHC scores of UBE4B level between GC tissue and adjacent normal tissue. C IHC scores of FAT4 level between GC tissue and adjacent normal tissue. D The Kaplan-Meier plot of overall survival by the expression of UBE4B in tumor microarrays related information ( n = 66 (high-expression) vs 28 (low-expression)). E The Kaplan-Meier plot of overall survival by the expression of FAT4 in tumor microarrays related information ( n = 46 (high-expression) vs 48 (low-expression)).

Article Snippet: The antibodies used in this study were as follows: UBE4B (18148-1-AP, Proteintech), FAT4 (A17212, ABclonal), FAT4 (NBP1-78381, Novus), P62 (#7695, Cell Signaling), LC3 (#12741, Cell Signaling), ubiquitin (10201-1-AP, Proteintech), Ki67 (#9449, Cell Signaling), HA (20543-1-AP, Proteintech), MYC (390003, Zenbio), and GAPDH (HC301-01, TransGen Biotech).

Techniques: Immunohistochemistry, Expressing

Screening hub genes related to efferocytosis in diabetic kidney macrophages. The GO enrichment analysis of macrophage subpopulations in 3-month-old (A) and 7-month-old mice (B) . (C) The chord diagram about the interaction among renal immune cells. (D) The Venn diagram illustrating the intersection between GSE195799 and the gene list of efferocytosis. (E) The PPI diagram, where the color varies from light to dark, signifies an ascending order of degree. (F–H) Violin diagrams of the distribution of CD36, ITGAM, and CX3CR1 in each cluster. GO, gene ontology; MIF, macrophage migration inhibitory factor; PPI, protein-protein interaction network.

Journal: Frontiers in Immunology

Article Title: Unveiling macrophage dynamics and efferocytosis-related targets in diabetic kidney disease: insights from single-cell and bulk RNA-sequencing

doi: 10.3389/fimmu.2025.1521554

Figure Lengend Snippet: Screening hub genes related to efferocytosis in diabetic kidney macrophages. The GO enrichment analysis of macrophage subpopulations in 3-month-old (A) and 7-month-old mice (B) . (C) The chord diagram about the interaction among renal immune cells. (D) The Venn diagram illustrating the intersection between GSE195799 and the gene list of efferocytosis. (E) The PPI diagram, where the color varies from light to dark, signifies an ascending order of degree. (F–H) Violin diagrams of the distribution of CD36, ITGAM, and CX3CR1 in each cluster. GO, gene ontology; MIF, macrophage migration inhibitory factor; PPI, protein-protein interaction network.

Article Snippet: Afterwards, the primary antibody incubation was performed at 4°C overnight, encompassing antibodies for CD36 (A19016, ABclonal, China), ITGAM (ab133357, Abcam, Cambridge, UK), and CX3CR1 (13885-1-AP, Proteintech, China).

Techniques: Migration

Validating the clinical relevance of hub molecules. (A–C) illustrating the distribution characteristics of the data via violin plots. Scatter plots describe the correlation between CD36 (D) , ITGAM (E) , and CX3CR1 (F) expression with clinical indicators. ***P<0.001.

Journal: Frontiers in Immunology

Article Title: Unveiling macrophage dynamics and efferocytosis-related targets in diabetic kidney disease: insights from single-cell and bulk RNA-sequencing

doi: 10.3389/fimmu.2025.1521554

Figure Lengend Snippet: Validating the clinical relevance of hub molecules. (A–C) illustrating the distribution characteristics of the data via violin plots. Scatter plots describe the correlation between CD36 (D) , ITGAM (E) , and CX3CR1 (F) expression with clinical indicators. ***P<0.001.

Article Snippet: Afterwards, the primary antibody incubation was performed at 4°C overnight, encompassing antibodies for CD36 (A19016, ABclonal, China), ITGAM (ab133357, Abcam, Cambridge, UK), and CX3CR1 (13885-1-AP, Proteintech, China).

Techniques: Expressing

Evaluation of target gene expression in DKD model. (A) Quantitative PCR analysis of ITGAM, CD36, and CX3CR1 mRNA expression. (B) Western blot showing the protein expression levels of ITGAM, CD36, and CX3CR1. (C) Quantitative analysis of protein band grayscale values for ITGAM, CD36, and CX3CR1. *P < 0.05, **P < 0.01, ***P<0.001.

Journal: Frontiers in Immunology

Article Title: Unveiling macrophage dynamics and efferocytosis-related targets in diabetic kidney disease: insights from single-cell and bulk RNA-sequencing

doi: 10.3389/fimmu.2025.1521554

Figure Lengend Snippet: Evaluation of target gene expression in DKD model. (A) Quantitative PCR analysis of ITGAM, CD36, and CX3CR1 mRNA expression. (B) Western blot showing the protein expression levels of ITGAM, CD36, and CX3CR1. (C) Quantitative analysis of protein band grayscale values for ITGAM, CD36, and CX3CR1. *P < 0.05, **P < 0.01, ***P<0.001.

Article Snippet: Afterwards, the primary antibody incubation was performed at 4°C overnight, encompassing antibodies for CD36 (A19016, ABclonal, China), ITGAM (ab133357, Abcam, Cambridge, UK), and CX3CR1 (13885-1-AP, Proteintech, China).

Techniques: Targeted Gene Expression, Real-time Polymerase Chain Reaction, Expressing, Western Blot